BioCentury
ARTICLE | Clinical News

Vismed sodium hyaluronate opthalmic solution regulatory update

June 29, 2009 7:00 AM UTC

FDA's Dermatologic and Ophthalmic Drugs Advisory Committee voted 6-1 that Rejena from Lantibio did not demonstrate adequate safety and efficacy to treat signs and symptoms of dry eye disease. Rejena i...